Cooper Companies, Inc. (The) (COO) Given Daily News Impact Score of 0.19
News articles about Cooper Companies, Inc. (The) (NYSE:COO) have trended somewhat positive this week, Accern Sentiment Analysis reports. Accern identifies positive and negative press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Cooper Companies, Inc. (The) earned a news impact score of 0.19 on Accern’s scale. Accern also gave news stories about the medical device company an impact score of 46.1783267447978 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
These are some of the news stories that may have effected Accern Sentiment’s scoring:
- K2M Group Holdings, Inc. (KTWO) and The Cooper Companies, Inc. (COO) closes with a move of -0.18% – Stocks Gallery (stocksgallery.com)
- Advice by Analysts to Buy Healthcare Stock: The Cooper Companies, Inc. (COO) – Street Observer (press release) (streetobserver.com)
- Cooper Tire shows manufacturing isn’t a ‘dirty job’ (toledoblade.com)
- Why Is Cooper Companies (COO) Down 7.7% Since the Last Earnings Report? – Nasdaq (nasdaq.com)
Cooper Companies, Inc. (NYSE:COO) opened at 241.03 on Thursday. The firm has a market cap of $11.80 billion, a price-to-earnings ratio of 34.57 and a beta of 0.54. Cooper Companies, Inc. has a 12-month low of $158.73 and a 12-month high of $256.39. The company has a 50-day moving average of $243.18 and a 200 day moving average of $228.77.
Cooper Companies, Inc. (The) (NYSE:COO) last released its earnings results on Thursday, August 31st. The medical device company reported $2.64 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.58 by $0.06. The company had revenue of $556.00 million for the quarter, compared to analyst estimates of $552.32 million. Cooper Companies, Inc. (The) had a net margin of 16.45% and a return on equity of 16.00%. The firm’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same quarter last year, the firm earned $2.30 EPS. Equities analysts expect that Cooper Companies, Inc. will post $9.73 EPS for the current fiscal year.
COO has been the topic of a number of recent research reports. BMO Capital Markets reiterated a “buy” rating and set a $255.00 price target on shares of Cooper Companies, Inc. (The) in a report on Thursday, July 13th. Jefferies Group LLC reiterated a “buy” rating and set a $250.00 price target on shares of Cooper Companies, Inc. (The) in a report on Thursday, July 6th. BidaskClub lowered shares of Cooper Companies, Inc. (The) from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 25th. Cleveland Research reiterated a “buy” rating on shares of Cooper Companies, Inc. (The) in a report on Tuesday, August 22nd. Finally, Zacks Investment Research upgraded shares of Cooper Companies, Inc. (The) from a “hold” rating to a “buy” rating and set a $277.00 price target on the stock in a report on Tuesday, August 22nd. Seven investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $261.67.
In other Cooper Companies, Inc. (The) news, CEO Paul L. Remmell sold 9,294 shares of the stock in a transaction on Friday, July 14th. The shares were sold at an average price of $248.46, for a total transaction of $2,309,187.24. Following the completion of the sale, the chief executive officer now owns 6,186 shares of the company’s stock, valued at approximately $1,536,973.56. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Gary S. Petersmeyer sold 3,977 shares of the stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $244.94, for a total transaction of $974,126.38. The disclosure for this sale can be found here. Insiders have sold a total of 14,892 shares of company stock valued at $3,678,270 in the last three months. 1.60% of the stock is currently owned by corporate insiders.
Cooper Companies, Inc. (The) Company Profile
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.
Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.